title: Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma.
authors.affiliation: Division of Pulmonary, Allergy, and Rheumatology Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
authors.forename: Badrul A
authors.initials: BA
authors.lastname: Chowdhury
authors.forename: Sally M
authors.initials: SM
authors.lastname: Seymour
authors.forename: Mark S
authors.initials: MS
authors.lastname: Levenson
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000318:Adrenergic beta-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents